Welcome to our drug delivery system initiative, where our ultimate goal is to use Vitality3D to fabricate tailored tissue scaffolds that are capable of treating infection while imparting bioinspired structural and bioactivity properties to promote the natural tissue regeneration. Bioactive and drug delivery therapies are gaining hug popularity among healthcare professionals due to the increasing prevalence of chronic and surgical wounds, bone infection, and bone cancer.  Such a medical situations present clinical challenges for surgeons and healthcare services. Condition such as osteomyelitis requires bone grafting solutions that not only provide proper framework for regeneration of the new bone tissue but also release a controlled profile of antimicrobial drugs to treat the contaminated site over the healing period. Moreover, statistics show that over 600 million will be living with diabetes by 2030, %25 of whom will develop a chronic none-healing wound in their lifetime. This will impose significant cost on economies, as it has already resulted in an annual economic burden exceeding $300 billion in US alone.  The advanced antimicrobial dressing solution protects wounds from infections caused by various pathogens and reduced the overall cost for wound management services.  We are exploring the possibility of using Vitality3D for the fabrication of customised drug-eluting scaffolds for both skin and bone tissue regeneration. We are discovering how our technology can empower bioscientist, R&D sectors, hospitals, and healthcare professionals to push the boundaries of what’s possible in fabrication of drug delivery systems to treat these debilitating medical conditions.